Case Report
Volume: 3 | Issue: 2 | Published: Sep 28, 2020 | Pages: 108 - 112 | DOI: 10.24911/JBCGenetics/183-1596702951
Infantile systemic hyalinosis: report of a case from Bahrain and review of literature
Authors: Zahra Alsahlawi , Fatema Naser Alfayez , Sayed Mohamed Hasan , Deena Mohammed , Emtethal Aljishi
Article Info
Authors
Zahra Alsahlawi
Pediatrician/Metabolic Disease and Clinical Genetics Consultant, Salmaniya Medical Complex, Kingdom of Bahrain
Fatema Naser Alfayez
College of Medicine and Medical Sciences, Arabian Gulf University, Kingdom of Bahrain
Sayed Mohamed Hasan
College of Medicine and Medical Sciences, Arabian Gulf University, Kingdom of Bahrain
Deena Mohammed
Intern at Salmaniya Medical Complex, Kingdom of Bahrain
Emtethal Aljishi
Intern at Salmaniya Medical Complex, Kingdom of Bahrain
Publication History
Received: August 06, 2020
Revised: August 27, 2020
Accepted: September 15, 2020
Published: September 28, 2020
Abstract
Background: Infantile systemic hyalinosis (ISH), an allelic form of hyaline fibromatosis syndrome, is a rare fatal autosomal recessive disorder that is caused by mutations in the CMG2/ANTRX2 gene encoding the transmembrane anthrax toxin receptor 2. It has a compound of features due to the accumulation of hyaline material in multiple organs including characteristic skin lesions, joint contractures, persistent diarrhea, and failure to thrive. The resulting severe malnutrition can be the cause of death in early infancy. Due to its rarity and early high fatality rate, timely diagnosis is difficult, and children with ISH may die undiagnosed. Case Presentation: In this report, we describe a 3-year-old female diagnosed with ISH after reviewing her clinical and laboratory workup in Salmaniya Medical Hospital. She was diagnosed with ISH based on the clinical presentation of severe skin lesions, painful joint contractures, and later developed renal tubular acidosis. Her diagnosis was confirmed with skin histopathology and identification of homozygous ANTRX2 mutation, c.652T>C, p.Cys218Arg, and Chr4 (GRCh37): g.80957171A>G. Conclusion: While the clinical outcome of the disease is poor without curative treatment, establishing an early diagnosis of ISH, beginning with clinical suspicion to molecular analysis, is important for accurate management as well as carrier and risk assessment of family members.
Keywords: Hyaline fibromatosis syndrome, infantile systemic hyalinosis, ISH, juvenile hyaline fibromatosis, ANTXR2